A recent study reveals a potential connection between Parkinson’s disease and the gut microbiome, suggesting that infection with a specific bacteria, known as Desulfovibrio, contributes to the development of the degenerative brain disorder.
Researchers at the University of Helsinki observed that the presence of these bacterial strains in Parkinson’s patients could lead to the aggregation of alpha-synuclein, a protein closely associated with the disease.
